Key Events This Week
May 5: Technical momentum shift with 2.70% gain
May 8: New 52-week high at Rs.574.45
May 8: Intraday high surge of 7.09%
May 8: Week closes at Rs.550.30 (+11.69%)
May 08
BSE+NSE Vol: 1.02 cr
May 5: Technical momentum shift with 2.70% gain
May 8: New 52-week high at Rs.574.45
May 8: Intraday high surge of 7.09%
May 8: Week closes at Rs.550.30 (+11.69%)
The next results date for Metropolis Healthcare Ltd is scheduled for 13 May 2026....
Read full news article
Surging past its previous peaks, Metropolis Healthcare Ltd touched a fresh 52-week high of Rs 574.45 on 08 Jun 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and outperformance relative to its sector and the broader market.
Read full news article
The Sensex declined by 0.57% on 08 Jun 2026, while Metropolis Healthcare Ltd surged 7.09%, reaching an intraday high of Rs 533. This 3.93 percentage-point outperformance over its Healthcare Services sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Metropolis Healthcare Ltd has exhibited a notable shift in technical momentum, moving from a mildly bearish to a mildly bullish trend, supported by a 3.35% gain in its share price on 5 May 2026. Despite mixed signals from key technical indicators, the stock’s recent performance and upgraded mojo grade suggest cautious optimism for investors in the healthcare services sector.
Read full news article
Metropolis Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Metropolis Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 09 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Metropolis Healthcare Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a strong day change of 3.57%, the stock’s broader trend signals remain mixed, with key metrics such as MACD, RSI, and moving averages offering a nuanced picture for investors navigating the healthcare services sector.
Read full news article
Metropolis Healthcare Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a recent modest decline in share price, the stock’s longer-term performance remains mixed against broader market benchmarks, prompting a reassessment of its outlook within the healthcare services sector.
Read full news articleThe Company will participate in the Q4 FY26 earnings conference call (i.e. post earnings/quarterly call) organized by Ambit Capital on Thursday May 14 2026 at 09:00 a.m. (IST) to discuss the financial results of the company for the quarter ended March 31 2026
Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve a) Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31 2026; and b) Declaration of 2nd interim dividend if any on the equity shares of the Company for the financial year 2025-26.
Schedule of Analyst / Institutional Investor Meeting
13 May 2026
Metropolis Healthcare Ltd has declared 200% dividend, ex-date: 11 Nov 25
No Splits history available
Metropolis Healthcare Ltd has announced 3:1 bonus issue, ex-date: 20 Mar 26
No Rights history available